Literature DB >> 16765397

Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda.

Dominique A Caugant1, Carole Fogg, Francis Bajunirwe, Patrice Piola, Rogers Twesigye, Fred Mutebi, L Oddvar Frøholm, Einar Rosenqvist, Vincent Batwala, Ingeborg S Aaberge, John-Arne Rottingen, Philippe J Guerin.   

Abstract

In southern Uganda, only sporadic cases of serogroup A meningococcal disease have been reported since 2000. As part of an immunogenicity study of the tetravalent meningococcal polysaccharide vaccine, nasopharyngeal swab samples were collected twice, 4 weeks apart, from 2-19-year-old healthy individuals in Mbarara, Uganda. Only 15 (2.0%) of the 750 individuals carried meningococci asymptomatically. Most of the strains were non-serogroupable and none were serogroup A. However, two individuals carried a serogroup W135 strain, sequence type (ST)-11, similar to the clone that was responsible for the epidemic in Burkina Faso in 2002. Our study further demonstrates the geographical spread of serogroup W135 ST-11 strain and thus the potential epidemic risk.

Entities:  

Mesh:

Year:  2006        PMID: 16765397     DOI: 10.1016/j.trstmh.2006.01.004

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  11 in total

1.  The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey.

Authors:  Rahmi Tuna Tekin; Ener Cagri Dinleyici; Mehmet Ceyhan; Adem Karbuz; Nuran Salman; Murat Sutçu; Zafer Kurugol; Yasemin Balliel; Melda Celik; Mustafa Hacimustafaoglu; Necdet Kuyucu; Meda Kondolot; Gülnar Sensoy; Ozge Metin; Soner Sertan Kara; Meltem Dinleyici; Omer Kılıç; Cihangul Bayhan; Venhar Gurbuz; Emre Aycan; Aygun Memedova; Arzu Karli; Gulçin Bozlu; Solmaz Celebi
Journal:  Hum Vaccin Immunother       Date:  2017-01-31       Impact factor: 3.452

2.  Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.

Authors:  Paul A Kristiansen; Fabien Diomandé; Stanley C Wei; Rasmata Ouédraogo; Lassana Sangaré; Idrissa Sanou; Denis Kandolo; Pascal Kaboré; Thomas A Clark; Abdoul-Salam Ouédraogo; Ki Ba Absatou; Charles D Ouédraogo; Musa Hassan-King; Jennifer Dolan Thomas; Cynthia Hatcher; Mamoudou Djingarey; Nancy Messonnier; Marie-Pierre Préziosi; Marc LaForce; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

Review 3.  Evolutionary and genomic insights into meningococcal biology.

Authors:  Holly B Bratcher; Julia S Bennett; Martin C J Maiden
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

4.  Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Authors:  Roberto Gasparini; Maurizio Comanducci; Daniela Amicizia; Filippo Ansaldi; Paola Canepa; Andrea Orsi; Giancarlo Icardi; Emanuela Rizzitelli; Gabriella De Angelis; Stefania Bambini; Monica Moschioni; Sara Comandi; Isabella Simmini; Giueseppe Boccadifuoco; Brunella Brunelli; Marzia Monica Giuliani; Mariagrazia Pizza; Donatella Panatto
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

5.  Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.

Authors:  Ulla Jounio; Annika Saukkoriipi; Holly B Bratcher; Aini Bloigu; Raija Juvonen; Sylvi Silvennoinen-Kassinen; Ari Peitso; Terttu Harju; Olli Vainio; Markku Kuusi; Martin C J Maiden; Maija Leinonen; Helena Käyhty; Maija Toropainen
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

6.  Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.

Authors:  Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

Review 7.  Meningococcal carriage and disease--population biology and evolution.

Authors:  Dominique A Caugant; Martin C J Maiden
Journal:  Vaccine       Date:  2009-05-21       Impact factor: 3.641

8.  Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.

Authors:  Philippe J Guerin; Lisbeth M Naess; Carole Fogg; Einar Rosenqvist; Loretxu Pinoges; Francis Bajunirwe; Carolyn Nabasumba; Ray Borrow; Leif O Frøholm; Salah Ghabri; Vincent Batwala; Rogers Twesigye; Ingeborg S Aaberge; John-Arne Røttingen; Patrice Piola; Dominique A Caugant
Journal:  PLoS Negl Trop Dis       Date:  2008-12-02

9.  Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.

Authors:  Paul A Kristiansen; Absatou Ky Ba; Idrissa Sanou; Abdoul-Salam Ouédraogo; Rasmata Ouédraogo; Lassana Sangaré; Fabien Diomandé; Denis Kandolo; Jennifer Dolan Thomas; Thomas A Clark; Marc Laforce; Dominique A Caugant
Journal:  BMC Infect Dis       Date:  2013-08-02       Impact factor: 3.090

10.  Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines.

Authors:  Lorenzo Argante; Michele Tizzoni; Duccio Medini
Journal:  BMC Med       Date:  2016-06-30       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.